Overview

Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to conduct a pilot study using biologic agents Avastin and Gleevec to treat progression of multivessel intraluminal pulmonary vein stenosis in children.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Boston Children's Hospital
Kathy Jenkins
Treatments:
Bevacizumab
Imatinib Mesylate